CNS Pharmaceuticals, Inc.
CNSP
$5.78
-$0.16-2.69%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -16.70M | -16.49M | -15.85M | -13.07M | -15.46M |
| Total Depreciation and Amortization | 14.70K | 4.50K | 3.70K | 3.70K | 3.80K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 111.10K | 130.30K | 190.10K | 232.40K | 1.08M |
| Change in Net Operating Assets | 3.16M | 1.13M | 1.84M | -3.40M | -6.48M |
| Cash from Operations | -13.41M | -15.22M | -13.81M | -16.23M | -20.86M |
| Capital Expenditure | -28.20K | -24.40K | -18.20K | -4.20K | -4.20K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -28.20K | -24.40K | -18.20K | -4.20K | -4.20K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -308.80K | -307.10K | -297.80K | -298.20K | -299.30K |
| Issuance of Common Stock | 21.72M | 5.52M | 14.05M | 18.55M | 30.97M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -111.60K | -65.60K | 816.40K | 870.50K | 832.00K |
| Cash from Financing | 21.30M | 5.15M | 14.57M | 19.13M | 31.50M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 7.86M | -10.10M | 739.10K | 2.89M | 10.64M |